Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?
NCT ID: NCT03066726
Last Updated: 2023-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
580 participants
OBSERVATIONAL
2017-05-15
2020-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of the CPR to Predict Adverse Outcomes in GDM Pregnancies
NCT03072563
Prediction of Late Fetal Growth Restriction Using Cerebroplacental Ratio
NCT04640467
Doppler and AFV for Outcome Prediction ın FGR
NCT05295667
Direct Measurements of Cervical Remodeling for Predicting Preterm Birth
NCT01175551
The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study
NCT02357667
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A secondary aim of the study is to analyze CPR as a continuous variable.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPR less than the 10%le
Group of patients with fetuses with cerebroplacental ratio less than 10%le
No interventions assigned to this group
CPR greater or equal than 10%le
Group of patients with fetuses with cerebroplacental ratio greater or equal than 10%le
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known fetal chromosomal anomaly
* Known fetal malformation
* Preeclampsia
* Fetal growth restriction
* Multiparity
* Prior cesarean section
* Placental abnormalities such as previa or accreta
* Pregestational diabetes
* Plan to deliver outside the Perinatal Research Consortium affiliated hospitals
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virtua Medical Group
OTHER
Columbia University
OTHER
Saint Peters University Hospital
OTHER
Winthrop University Hospital
OTHER
New York Presbyterian Queens
UNKNOWN
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Todd Rosen, MD
Director, Maternal-Fetal Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Todd Rosen, MD
Role: PRINCIPAL_INVESTIGATOR
Rutgers, The State University of New Jersey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, United States
Saint Peters University Hospital
New Brunswick, New Jersey, United States
Virtua Medical Group
Sewell, New Jersey, United States
New York Presbyterian-Queens Hospital
Flushing, New York, United States
Winthrop University Hospital
Mineola, New York, United States
Columbia University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Prior T, Mullins E, Bennett P, Kumar S. Prediction of intrapartum fetal compromise using the cerebroumbilical ratio: a prospective observational study. Am J Obstet Gynecol. 2013 Feb;208(2):124.e1-6. doi: 10.1016/j.ajog.2012.11.016. Epub 2012 Nov 15.
Figueras F, Savchev S, Triunfo S, Crovetto F, Gratacos E. An integrated model with classification criteria to predict small-for-gestational-age fetuses at risk of adverse perinatal outcome. Ultrasound Obstet Gynecol. 2015 Mar;45(3):279-85. doi: 10.1002/uog.14714. Epub 2015 Jan 27.
DeVore GR. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol. 2015 Jul;213(1):5-15. doi: 10.1016/j.ajog.2015.05.024.
Morales-Rosello J, Khalil A, Morlando M, Papageorghiou A, Bhide A, Thilaganathan B. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term. Ultrasound Obstet Gynecol. 2014 Mar;43(3):303-10. doi: 10.1002/uog.13319.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RU10312017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.